Science for a better future - R&D
about ADMIR
Key Feature
12 patents
Secrete knowhow
3M€ R&D funding
about research
Today R&D
As the James Webb telescope uses the infrared spectroscopic technology to reveal the chemical composition of distant and huge objects of our universe, the ADMIR microscope exploits the same principles to provide bio-chemical mapping of tiny objects of the living world. Our researches have led to a drastic reduction of the analysis time down to one minute per image instead of hours with conventional systems. These technological breakthroughs have been achieved inside our former R&D team that has an international recognition in the field of spectroscopic sensors in the mid-infrared (Mix@d-IR) range. High-brightness, highly monochromatic quantum cascade (QCL) MIR lasers have in particular been studied (Fedeli & al, 2018) (Coutard & al, 2020). ADMIR also relies on more than 20 years of development of infrared imagers based on bolometer arrays (Yon & al, 2014). ADMIR has been built around these core competences.
From now on, the medical practitioners can use this Mid-IR spectroscopic analysis, which was so far reserved for the research world. In particular, ADMIR offers powerful analysis tool for tissues, cells, bacteria colonies or yeasts.
our technology
Oncology
One infrared scanner
Our scanners are designed to acquire visible and infrared images of unstained tissue slides
Two applications
MIRSTAIN
Optical and numerical tissue coloration
MIRDIAG
Biochemical analysis – Diagnostic metabolomic
our technology
Microbiology
Microbial colonies such as presented above are acquired with the ADMIR system at eight different wavenumbers. Computer vision and machine learning processes then allow to classify the optical fingerprints. This process correctly identify up to 97% of colonies. Current works focus on improving reliability, expanding the number of target species, as well as developping new tools and algorithms dedicated to strain-typing.
our futurE
What’s next
At mid-term, ADMIR has the ambition of providing an efficient diagnosis tool for cancers (lung, breast, prostate…) and infectious diseases or for any analyses in pharma or biotech. In long term, ADMIR intends to offer a small enough system to be used inside an endoscope removing the necessity to have a biopsy. This opens a new route toward a fast and weakly invasive tissue analysis.